ACSL4 and breast carcinoma: Finally, ACSL4 has been demonstrated to be one of three downstream targets of FOXM1-induced migration in MDA-MB-231 cells [74] as well as a mediator of the tumorigenic role of PADI2 in conferring susceptibility to breast cancer [75].